9:00 AM - 5:00 PM

Our Hours Mon. - Fri.

310.774.1437

Call Us For Free Consultation

Facebook

Twitter

Revance Prices $100M Preapproved Offering Amid Shutdown

Tiomkin Law Offices of Elliott Tiomkin > Legal News  > Revance Prices $100M Preapproved Offering Amid Shutdown

Revance Prices $100M Preapproved Offering Amid Shutdown

Law360 (January 17, 2019, 7:16 PM EST) — Biotechnology company Revance Therapeutics said on Thursday that it has priced a $100 million follow-on offering by way of a preapproved U.S. Securities and Exchange Commission filing that will allow the…

Call Now ButtonCall For Free Consultation